Autosomal Dominant Hypocalcemia Latest Advances

Regarding Non-Classical Presentations of Rare Hereditary Hypoparathyroidism: A Case Series of CASR, GNA11, and GATA3 Mutations in Parathyroidology.

Journal: Clinical endocrinology

Published: April 19, 2026

Long-acting parathyroid hormone receptor agonist rectifies hypocalcemia in autosomal dominant hypocalcemia type 1 mice.

Journal: The Journal of clinical investigation

Published: February 19, 2026

Autosomal dominant hypocalcemia type 1: Status quo of tailored management and future perspectives.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: February 09, 2026

A novel gain-of-function mutation (W818R) of calcium-sensing receptor in a family with autosomal dominant hypocalcemia type 1.

Journal: Frontiers in endocrinology

Published: February 08, 2026

Refractory Hypocalcemia from Combined Autosomal Dominant Hypocalcemia Type 2 and Postsurgical Hypoparathyroidism.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: January 30, 2026

Continuous subcutaneous recombinant PTH(1-34) infusion improves serum calcium and phosphate homeostasis in children with autosomal dominant hypocalcemia type 1 refractory to standard-of-care treatment.

Journal: European journal of endocrinology

Published: January 09, 2026

Complications of Pseudohypoparathyroidism and Congenital Forms of Hypoparathyroidism in Children

Journal: Problemy endokrinologii

Published: December 26, 2025

Clinical and genetic insights into Autosomal Dominant Hypocalcemia type 1: a single-center case series including genotype-phenotype correlations, pregnancy outcomes, and novel CASR variants.

Journal: Journal of endocrinological investigation

Published: December 19, 2025

Observation of an index case of an autosomal dominant familial hypoparathyroidism revealed by recurrent hypocalcemia: a case report

Journal: The Pan African medical journal

Published: December 01, 2025

Non-Classical Presentations of Rare Hereditary Hypoparathyroidism: A Case Series of CASR, GNA11 and GATA3 Mutations.

Journal: Clinical endocrinology

Published: November 26, 2025

Repurposing osteoporosis medications for other diseases: a narrative review by the European Calcified Tissue Society (ECTS).

Journal: Bone

Published: October 19, 2025

Novel Variants and Clinical Heterogeneity in Pediatric Calcium Metabolism Disorders Identified Through High-Yield Tiered Genetic Testing in a Taiwanese Cohort.

Journal: Medicina (Kaunas, Lithuania)

Published: August 29, 2025

Autosomal Dominant Hypocalcemia Latest Advances

Find the Latest Research About Autosomal Dominant Hypocalcemia

Regarding Non-Classical Presentations of Rare Hereditary Hypoparathyroidism: A Case Series of CASR, GNA11, and GATA3 Mutations in Parathyroidology.

Regarding Non-Classical Presentations of Rare Hereditary Hypoparathyroidism: A Case Series of CASR, GNA11, and GATA3 Mutations in Parathyroidology.

Long-acting parathyroid hormone receptor agonist rectifies hypocalcemia in autosomal dominant hypocalcemia type 1 mice.

Long-acting parathyroid hormone receptor agonist rectifies hypocalcemia in autosomal dominant hypocalcemia type 1 mice.

Autosomal dominant hypocalcemia type 1: Status quo of tailored management and future perspectives.

Autosomal dominant hypocalcemia type 1: Status quo of tailored management and future perspectives.

A novel gain-of-function mutation (W818R) of calcium-sensing receptor in a family with autosomal dominant hypocalcemia type 1.

A novel gain-of-function mutation (W818R) of calcium-sensing receptor in a family with autosomal dominant hypocalcemia type 1.

Refractory Hypocalcemia from Combined Autosomal Dominant Hypocalcemia Type 2 and Postsurgical Hypoparathyroidism.

Refractory Hypocalcemia from Combined Autosomal Dominant Hypocalcemia Type 2 and Postsurgical Hypoparathyroidism.

Continuous subcutaneous recombinant PTH(1-34) infusion improves serum calcium and phosphate homeostasis in children with autosomal dominant hypocalcemia type 1 refractory to standard-of-care treatment.

Continuous subcutaneous recombinant PTH(1-34) infusion improves serum calcium and phosphate homeostasis in children with autosomal dominant hypocalcemia type 1 refractory to standard-of-care treatment.

Complications of Pseudohypoparathyroidism and Congenital Forms of Hypoparathyroidism in Children

Complications of Pseudohypoparathyroidism and Congenital Forms of Hypoparathyroidism in Children

Clinical and genetic insights into Autosomal Dominant Hypocalcemia type 1: a single-center case series including genotype-phenotype correlations, pregnancy outcomes, and novel CASR variants.

Clinical and genetic insights into Autosomal Dominant Hypocalcemia type 1: a single-center case series including genotype-phenotype correlations, pregnancy outcomes, and novel CASR variants.

Observation of an index case of an autosomal dominant familial hypoparathyroidism revealed by recurrent hypocalcemia: a case report

Observation of an index case of an autosomal dominant familial hypoparathyroidism revealed by recurrent hypocalcemia: a case report

Non-Classical Presentations of Rare Hereditary Hypoparathyroidism: A Case Series of CASR, GNA11 and GATA3 Mutations.

Non-Classical Presentations of Rare Hereditary Hypoparathyroidism: A Case Series of CASR, GNA11 and GATA3 Mutations.

Repurposing osteoporosis medications for other diseases: a narrative review by the European Calcified Tissue Society (ECTS).

Repurposing osteoporosis medications for other diseases: a narrative review by the European Calcified Tissue Society (ECTS).

Novel Variants and Clinical Heterogeneity in Pediatric Calcium Metabolism Disorders Identified Through High-Yield Tiered Genetic Testing in a Taiwanese Cohort.

Novel Variants and Clinical Heterogeneity in Pediatric Calcium Metabolism Disorders Identified Through High-Yield Tiered Genetic Testing in a Taiwanese Cohort.